Azalanstat is an investigational anti-obesity and hypocholesterolemic agent that functions as a lanosterol 14α-demethylase inhibitor to reduce cholesterol biosynthesis. This category provides essential… Read more
Azalanstat is an investigational anti-obesity and hypocholesterolemic agent that functions as a lanosterol 14α-demethylase inhibitor to reduce cholesterol biosynthesis. This category provides essential materials for pharmaceutical research, including reference standards of the active pharmaceutical ingredient, along with related impurities, metabolites, and stable isotope-labelled compounds. These reference materials are critical for laboratories engaged in rigorous analytical testing, impurity profiling, and method validation to ensure the quality and consistency of drug substance development. By utilizing these characterized standards, researchers can perform accurate identification and quantification, supporting the stringent regulatory requirements needed for pharmaceutical quality control.